241 related articles for article (PubMed ID: 29169331)
41. Use of antihypertensive medication after ischemic stroke in young adults and its association with long-term outcome.
van Dongen MME; Aarnio K; Martinez-Majander N; Pirinen J; Sinisalo J; Lehto M; Kaste M; Tatlisumak T; de Leeuw FE; Putaala J
Ann Med; 2019 Feb; 51(1):68-77. PubMed ID: 30592437
[TBL] [Abstract][Full Text] [Related]
42. Sociodemographic factors are associated with utilisation of statins after ischaemic stroke/TIA.
Geary L; Aronius J; Wettermark B; Hasselström J; Sjöborg B; von Euler M
Int J Clin Pract; 2017 Mar; 71(3-4):. PubMed ID: 28371022
[TBL] [Abstract][Full Text] [Related]
43. Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care.
Simpson CR; Wilson C; Hannaford PC; Williams D
Stroke; 2005 Aug; 36(8):1771-5. PubMed ID: 16040591
[TBL] [Abstract][Full Text] [Related]
44. Use of medications for secondary prevention in stroke patients at hospital discharge in Australia.
Eissa A; Krass I; Bajorek BV
Int J Clin Pharm; 2014 Apr; 36(2):384-93. PubMed ID: 24519632
[TBL] [Abstract][Full Text] [Related]
45. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association).
Coull BM; Williams LS; Goldstein LB; Meschia JF; Heitzman D; Chaturvedi S; Johnston KC; Starkman S; Morgenstern LB; Wilterdink JL; Levine SR; Saver JL; ;
Stroke; 2002 Jul; 33(7):1934-42. PubMed ID: 12105379
[No Abstract] [Full Text] [Related]
46. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
Davis SM; Donnan GA
N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
[No Abstract] [Full Text] [Related]
47. Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: a consecutive cross-sectional survey.
Wang YL; Wu D; Nguyen-Huynh MN; Zhou Y; Wang CX; Zhao XQ; Liao XL; Liu LP; Wang YJ;
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):775-81. PubMed ID: 20456429
[TBL] [Abstract][Full Text] [Related]
48. From head to toe: Sex and gender differences in the treatment of ischemic cerebral disease.
Falsetti L; Viticchi G; Buratti L; Balucani C; Marra AM; Silvestrini M
Pharmacol Res; 2017 Jul; 121():240-250. PubMed ID: 28506796
[TBL] [Abstract][Full Text] [Related]
49. Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis.
Turner GM; Calvert M; Feltham MG; Ryan R; Fitzmaurice D; Cheng KK; Marshall T
PLoS Med; 2016 Nov; 13(11):e1002169. PubMed ID: 27846215
[TBL] [Abstract][Full Text] [Related]
50. Socioeconomic Inequalities in the Prescription of Oral Anticoagulants in Stroke Patients With Atrial Fibrillation.
Sjölander M; Eriksson M; Asplund K; Norrving B; Glader EL
Stroke; 2015 Aug; 46(8):2220-5. PubMed ID: 26081841
[TBL] [Abstract][Full Text] [Related]
51. Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register.
Asberg S; Henriksson KM; Farahmand B; Asplund K; Norrving B; Appelros P; Stegmayr B; Asberg KH; Terént A
Stroke; 2010 Jul; 41(7):1338-42. PubMed ID: 20522818
[TBL] [Abstract][Full Text] [Related]
52. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
[TBL] [Abstract][Full Text] [Related]
53. [Secondary prevention of ischemic non cardioembolic stroke].
Armario P; Pinto X; Soler C; Cardona P
Clin Investig Arterioscler; 2015; 27(6):287-300. PubMed ID: 25771074
[TBL] [Abstract][Full Text] [Related]
54. Discontinuation of antiplatelet treatment and risk of recurrent stroke and all-cause death: a cohort study.
Ostergaard K; Pottegård A; Hallas J; Bak S; dePont Christensen R; Gaist D
Neuroepidemiology; 2014; 43(1):57-64. PubMed ID: 25323533
[TBL] [Abstract][Full Text] [Related]
55. Secondary prevention after ischemic stroke. Evolution over time in practice.
Girot M; Mackowiak-Cordoliani MA; Deplanque D; Hénon H; Lucas C; Leys D
J Neurol; 2005 Jan; 252(1):14-20. PubMed ID: 15654550
[TBL] [Abstract][Full Text] [Related]
56. Secondary medical prevention after primary vascular surgery between 1996 and 2006: a shift towards more evidence-based treatment.
Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
Eur J Prev Cardiol; 2013 Oct; 20(5):763-70. PubMed ID: 22637739
[TBL] [Abstract][Full Text] [Related]
57. Association of antiplatelet therapy with lower risk of death and recurrent cerebrovascular events after ischemic stroke--results from the China Ischemic Stroke Registry Study.
Ding D; Lu CZ; Fu JH; Hong Z;
Circ J; 2009 Dec; 73(12):2342-7. PubMed ID: 19822978
[TBL] [Abstract][Full Text] [Related]
58. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
59. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
Yu HC; Tsai YF; Chen MC; Yeh CH
Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
[TBL] [Abstract][Full Text] [Related]
60. Prescription of Pharmacotherapy and the Incidence of Stroke in Patients With Symptoms of Peripheral Artery Disease.
Nastasi DR; Smith JR; Moxon JV; Trollope A; Golledge J
Stroke; 2018 Dec; 49(12):2953-2960. PubMed ID: 30571405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
